What’s Next in MBC? Insights from ASCO Annual Meeting 2026
What were some of the biggest metastatic breast cancer updates from the 2026 ASCO Annual Meeting and which findings are already changing care?
In this episode of OUR MBC Life, Dr. Chen breaks down key research findings and what they mean for people living with metastatic breast cancer. This episode also includes a Q & A featuring questions from our community about treatment, side effects and what these new advances mean for people living with metastatic breast cancer.
ASCO 2025: What’s New for MBC?
In our Season 11 opening episode, we’re bringing you the latest updates from the 2025 ASCO Annual Meeting on metastatic breast cancer. Dr. Ashley Schreier, breast oncologist at Weill Cornell Medicine, breaks down key research and explains what it could mean for people living with MBC.
Report Back From ASCO 2024: What’s the Latest in HR+ MBC?
We are thrilled to present an audio version of SHARE Cancer Support’s webinar “Report Back from ASCO 2024: Latest Updates on HR+ Metastatic Breast Cancer (MBC)”.
This episode is an in-depth report from the ASCO 2024 Annual Meeting, featuring the latest advancements and research in HR+ MBC. Hear from Dr. Kevin Kalinsky as we dive into the findings from the DESTINY-Breast06 and postMONARCH trials, exploring their implications and potential impact on treatment strategies.